• Molecular & Cellular Toxicology
• /
• 제4권1호
• /
• pp.5-10
• /
• 2008

The effect of obesity on the drug-metabolizing enzymes remains an important issue for clinician since obesity is a world wide epidemic problem. However, little is known about the effects of obesity on flavincontaining monooxygenase (FMO) production and activity. We show here for the first time that in vivo FMO activity determined by urinary ranitidine (RA) metabolites ratio in human, was higher in subjects with a high body mass index (BMI, kg/$m^2$, 21.97-30.32) than in those with an intermediate BMI (range 19.38-21.83). Moreover, there was a significant correlation between FMO activity and BMI in 209 subjects. In high fat diet-induced obese mice, we also observed that the hepatic expression of FMO (225% of lean mice) and the activity measured by the RA Noxidation rate ($513{\pm}58.1$ vs. $349{\pm}66.0$ pmol/hr per mg protein) were significantly higher than in lean mice fed a control diet. Unknown factors rather than leptin or insulin appeared to regulate the hepatic FMO production. Thus, FMO activity may be increased in obese or overweight individuals. Moreover, the regulation of FMO activity in subjects with morbid obesity, with or without complications and its clinical implications, should be investigated further.

• 한국식품영양과학회지
• /
• 제42권1호
• /
• pp.26-32
• /
• 2013

본 연구는 마우스에 고지방식이로 비만을 유도하면서 핑거루트 추출물(BPE)의 비만 억제 효과를 평가하는 것이었다. C57BL/6J 마우스를 두개의 실험군으로 나누어 8주 동안 각각 고지방식이와 고지방식이에 0.5%의 BPE를 보충한 식이를 급여하였다. BPE는 식이섭취량에는 영향을 주지 않으면서도 고지방식이군과 비교하여 유의적으로 체중증가를 줄이고, 내장지방의 축적을 억제하였다. 또한 BPE를 급여한 군은 고지방식이군과 비교하여 혈중 지질, 간지질의 축적, 혈중 렙틴 농도를 감소시켰다. RT-PCR 분석 결과, 부고환지방내에서의 $C/EBP{\alpha}$와 $PPAR{\gamma}2$의 발현수준이 고지방식이 대비 각각 1.30배와 1.16배 증가하였다. 결론적으로 BPE는 고지방식이로 유도된 비만 마우스 모델에서 내장지방의 축적을 감소시키고, 이상지질혈증 개선을 통해 항비만 효과를 나타내는 것으로 판단된다.

• Nutrition Research and Practice
• /
• 제16권1호
• /
• pp.46-59
• /
• 2022

BACKGROUND/OBJECTIVES: Aster yomena (Kitam.) Honda (AY) has remarkable bioactivities, such as antioxidant, anti-inflammation, and anti-cancer activities. On the other hand, the effects of AY against obesity-induced insulin resistance have not been reported. Therefore, this study examined the potential of AY against obesity-associated insulin resistance in high-fat diet (HFD)-fed mice. MATERIALS/METHODS: An obesity model was established by feeding C57BL/6J mice a 60% HFD for 16 weeks. The C57BL6/When ethyl acetate fraction from AY (EFAY) at doses of 100 and 200 mg/kg/day was administered orally to mice fed a HFD for the last 4 weeks. Normal and control groups were administered water orally. The body weight and fasting blood glucose were measured every week. Dietary intake was measured every other day. After dissection, blood and tissues were collected from the mice. RESULTS: The administration of EFAY reduced body and organ weights significantly compared to HFD-fed control mice. The EFAY-administered groups also improved the serum lipid profile by decreasing the triglyceride, total cholesterol, and low-density lipoprotein compared to the control group. In addition, EFAY ameliorated the insulin resistance-related metabolic dysfunctions, including the fasting blood glucose and serum insulin level, compared to the HFD-fed control mice. The EFAY inhibited lipid synthesis and insulin resistance by down-regulation of hepatic fatty acid synthase and up-regulation of the AMP-activated protein kinase pathway. EFAY also reduced lipid peroxidation in the liver, indicating that EFAY protected hepatic injury induced by obesity. CONCLUSIONS: These results suggest that EFAY improved obesity-associated insulin resistance by regulating the lipid and glucose metabolism, suggesting that AY could be used as a functional food to prevent obesity and insulin resistance.

• Archives of Pharmacal Research
• /
• 제27권1호
• /
• pp.48-52
• /
• 2004

DA-11004 is a synthetic, potent NADP-dependent isocitrate dehydrogenase (IDPc) inhibitor where $IC_{50}$ for IDPc is 1.49 $\mu$M. The purpose of this study was to evaluate the effects of DA-11004 on the high fat high sucrose (HF)-induced obesity in male C57BL/6J mice. After completing a 8-week period of experimentation, the mice were sacrificed 1hr after the last DA-11004 treatment and their blood, liver, and adipose tissues (epididymal and retroperitoneal fat)were collected. There was a significant difference in the pattern of increasing body weight between the HF control and the DA-11004 group. In the DA-11004 (100 mg/kg) treated group the increase in body weight significantly declined and a content of epididymal fat and retroperitoneal fat was also significantly decreased as opposed to the HF control. DA-11004 (100 mg/kg) inhibited the IDPc activity, and thus, NADPH levels in plasma and the levels of free fatty acid (FFA) or glucose in plasma were less than the levels of the HF control group. In conclusion, DA-11004 inhibited the fatty acid synthesis in adipose tissues via IDPc inhibition, and it decreased the plasma glucose levels and FFA in HF diet-induced obesity of C57BL/6J mice.

• 대한의생명과학회지
• /
• 제14권3호
• /
• pp.131-137
• /
• 2008

Adipogenesis is a complex sequence of events that culminates in the differentiation of fibroblast-like preadipocytes into specialized lipid-filled adipocytes and also involves a cascade of expression of many transcription factors such as peroxisome proliferator-activated receptor ${\gamma}(PPAR{\gamma})$ and CCAAT/enhancer-binding proteins (C/EBPs). $PPAR{\gamma}$ and C/EBPs transcriptionally transactivate adipocyte specific genes, including fatty acid transport protein (FAT/CD36) and leptin. To determine whether $17{\beta}$-estradiol modulates $C/EBP{\alpha}$ actions on adipogenesis in high fat diet-fed female ovariectomized (OVX) C57BL/6 mice, mice were treated with $17{\beta}$-estradiol for 7 days and the effects of $17{\beta}$-estradiol on adipose tissue mass and expression of adipocyte specific gene as well as $C/EBP{\alpha}$ were measured. Compared to vehicle-treated OVX control mice, OVX mice treated with $17{\beta}$-estradiol for 7 days had lower adipose tissue weights that were similar to weights in high fat diet-fed sham-operated (Sham) mice. OVX mice showed the increased expression of $C/EBP{\alpha}$ mRNA compared with Sham mice. However, $17{\beta}$-estradiol treatment in OVX mice inhibited OVX induced-$C/EBP{\alpha}$ activation, indicating that $17{\beta}$-estradiol may act as an inhibitor of $C/EBP{\alpha}$ action. Moreover, $17{\beta}$-estradiol decreased mRNA levels of adipocyte marker genes, such as lipoprotein lipase, FAT/CD36 and leptin, to levels in Sham mice. These results suggest that down-regulation of adipogenesis by $17{\beta}$-estradiol may be due to reduced adipose $C/EBP{\alpha}$ activities in female OVX C57BL/6 mice.

• 한국식품영양과학회지
• /
• 제44권5호
• /
• pp.641-648
• /
• 2015

고지방 고콜레스테롤 식이를 급여한 마우스에서 황칠나무 잎 추출물이 체내 지질 상태에 미치는 영향을 보기 위해 본 실험을 실시하였다. 실험 결과 황칠나무 추출물을 투여한 마우스의 체중이 모두 control군에 비해 감소하였다. 혈장과 간장의 TG, TC 및 혈장 LDL-C 농도도 control군에 비해 유의적으로(P<0.05) 감소하였으며, 혈장 HDL-C의 농도는 control군이 normal군보다 유의적으로 낮아졌고 DA-200군, DE-200군은 normal군의 수준까지 증가하였다(P<0.05). 간장, 비장, 고환 지방의 상대 무게와 혈장 인슐린 농도는 normal군에 비해 control군이 매우 높았으나 황칠나무 잎 추출물을 투여했을 때는 추출방법에 상관없이 농도에 비례적으로 인슐린 농도가 감소되었다. 그리고 모든 황칠나무 투여군의 간 조직 AST, ALT 활성과 MDA 농도 및 SOD 활성도 변화되었는데 AST, ALT 활성과 MDA 농도는 control군에 비해 낮아졌고 SOD 활성은 control군에 비해 증가하였다(P<0.05). 특히 DE-200군의 ALT 활성 및 DA-200군, DE-200군의 MDA 농도가 normal군의 수준까지 감소되었다(P<0.05). 또한 hematoxylin과 eosin 염색을 통해 황칠나무 잎 추출물이 간세포의 지질 침착 정도를 개선하는 것을 확인하였다. 이상의 결과를 통해 황칠나무 잎 추출물은 추출용매와 추출물의 농도에 따라 약간의 차이는 있으나 모두 고지방 고콜레스테롤 식이를 급여한 마우스의 체내 지질 상태의 개선에 영향을 미치는 것으로 확인되었다.

• Journal of Nutrition and Health
• /
• 제57권2호
• /
• pp.171-184
• /
• 2024

Purpose: Although activating thermogenic adipocytes is a promising strategy to reduce the risk of obesity and related metabolic disorders, emerging evidence suggests that it is difficult to induce adipocyte thermogenesis in obesity. Therefore, this study aimed to investigate the regulation of adipocyte thermogenesis in diet-induced obesity. Methods: Adipose progenitor cells were isolated from the white and brown adipose tissues of control diet (CD) or high-fat diet (HFD) fed mice, and fully differentiated white and brown adipocytes were treated with β-agonists or 18-carbon fatty acids for β-adrenergic activation or peroxisome proliferator-activated receptor (PPAR) activation. Results: Compared to the CD-fed mice, the expression of uncoupling protein 1 (Ucp1) was lower in the white adipose tissue of the HFD-fed mice; however, this was not observed in the brown adipose tissue. The expression of peroxisome proliferator-activated receptor gamma (Pparg) was lower in the brown adipose progenitor cells isolated from HFD-fed mice than in those isolated from the CD-fed mice. Norepinephrine (NE) treatment exerted lesser effect on peroxisome proliferator-activated receptor-γ coactivator (Pgc1a) upregulation in white adipocytes derived from HFD-fed mice than those derived from CD-fed mice. Regardless which 18-carbon fatty acids were treated, the expression levels of thermogenic genes including Ucp1, Pgc1a, and positive regulatory domain zinc finger region protein 16 (Prdm16) were higher in the white adipocytes derived from HFD-fed mice. Oleic acid (OLA) and γ-linolenic acid (GLA) upregulated Pgc1a expression in white adipocytes derived from HFD-fed mice. Brown adipocytes derived from HFD-fed mice had higher expression levels of Pgc1a and Prdm16 compared to their counterparts. Conclusion: These results indicate that diet-induced obesity may downregulate brown adipogenesis and NE-induced thermogenesis in white adipocytes. Also, HFD feeding may induce thermogenic gene expression in white and brown primary adipocytes, and OLA and GLA could augment the expression levels.

• 한국식품영양과학회지
• /
• 제35권8호
• /
• pp.1005-1009
• /
• 2006

복령의 비만예방 및 개선효과에 대해 검토하기 위한 일환으로 복령추출물의 혈중 지질성상에 미치는 영향을 연구하였다. 마우스를 대조군, 고지방식이군(HF), 고지방식이+열수 추출물 첨가군(HF+WE), 고지방식이+에탄올 추출물 첨가군(HF+EE) 네 군으로 나누어 각각 4주간 투여하였다. 사료섭취량은 대조군, 고지방식이군 및 추출물 첨가군에서 유의 있는 차이가 없었다. 체중증가량은 대조군, 고지방식이군 및 열수 추출물 첨가군에서 유의 있는 차이는 없었으나, 에탄올 첨가군(HF+EE)에서 체중증가가 낮게 나타났다. 또한 대조군 및 고지방식이 투여군에 비해 HF+EE군에서 간 중량도 감소하였다. 그러나 부고환 지방조직 중량은 대조군에 비해 고지방식이군 및 추출물 첨가군 모두 약 1.4배 증가하였다. 혈중 트리글리세리드, 총 콜레스테롤 함량은 고지방식이군에서 증가하였는데, 에탄올 추출물 첨가군에서 유의 있게 감소하였다. 혈중 LDL-콜레스테롤은 고지방식이군에서 크게 증가하는데, 에탄올 추출물 첨가군에서 감소하였다. 또한 혈중 HDL-콜레스테롤 함량은 고지방식이군에서 감소하는데, 에탄올 추출물 첨가군에서 증가하였다. 간의 트리글리세리드 및 콜레스테롤 함량은 실험군 간에 유의 있는 차이를 보이지 않았다. 이상의 결과는 복령의 에탄올 추출물 투여로 고지방식이 투여로 인한 마우스의 혈중 지방분포를 개선할 수 있음을 제시해주고 있다.

• 한국식품영양과학회지
• /
• 제39권5호
• /
• pp.677-683
• /
• 2010

본 연구는 고지방을 급여한 마우스의 체내 지질개선 및 항산화 방어계에 미치는 갈대순의 영향을 구명하고자 하였다. 4주령의 ICR마우스(n=24)를 1주일간 적응시킨 후 정상식이를 급여한 정상군, 고지방을 급여한 고지방군, 고지방-갈대순분말 급여군으로 나누어 8주간 사육하였다. 갈대순분말은 사람이 하루에 3잔의 차를 마시는 양을 고려하여 식이에 1% 수준이 되도록 첨가 조제하여 급여하였다. 갈대순분말군의 체중, 일일 식이섭취량과 에너지섭취량은 고지방군에 비하여 감소하는 경향이었다. 갈대순분말 급여 시 혈장의 총 콜레스테롤 함량은 고지방군에 비하여 19% 감소되었고 중성지질 함량은 36% 유의적인 감소를 보였다. 갈대순분말은 고지방식이로 축적된 간 조직의 중성지질 함량 변화에는 영향을 미치지 않았으나 콜레스테롤 함량은 고지방군에 비하여 유의적으로 낮추었다. 심장조직의 중성지질과 콜레스테롤 함량 역시 정상군에 비하여 고지방군이 각각 145%, 112%의 유의적인 증가를 나타내었으나 갈대순분말 급여로 중성지질 함량은 감소경향을 보였으며 콜레스테롤 함량은 정상군과 유사한 수준으로 개선되었다. 갈대순분말은 고지방군에 비하여 분변으로의 중성지질과 콜레스테롤 배설을 각각 27%와 28% 유의적으로 증가시켰다. 갈대순분말은 간 조직의 지방산 산화에는 영향을 미치지 않았고 지방산 합성효소 활성을 유의적으로 억제하였다. 간 조직 중의 HMG-CoA reductase와 ACAT 활성도 역시 갈대순급여군이 고지방군에 비하여 유의적으로 낮았다. 적혈구 중의 SOD와 CAT 활성은 정상군에 비하여 고지방식이 급여 시 유의적인 증가를 보였으나 GSH-Px 활성은 고지방식이로 인한 변화가 관찰되지 않았다. 반면, 갈대순분말 급여는 적혈구의 SOD와 CAT 활성과 지질과산화물 함량을 고지방군에 비하여 유의적으로 낮추었다. 이와 같이 갈대순분말은 고지방식 이를 급여한 마우스의 간 조직에서의 지방산과 콜레스테롤 합성을 저해하고 분변으로의 지질배설을 증가시킴으로써 혈장 지질개선에 효과적이었으며 적혈구의 항산화 효소활성도와 지질과산화물 함량도 개선하는 것으로 나타났다.

• 한방재활의학과학회지
• /
• 제28권3호
• /
• pp.1-11
• /
• 2018

Objectives This study was designed to evaluate the efficacy of Seungyangjeseup-tang on obesity by using 3T3-L1 cells and high fat diet mice. Methods In vitro, Seungyangjeseup-tang extract (SYJST) (10, 50, 100, 200, 400, $800{\mu}g/mL$) ware added in 3T3-L1 cells. SYJST cytotoxicity was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assasy. Adipocyte differentiation was measured by Oil Red-O staining. In vivo, the experimental animals were divided into five groups: normal diet-fed normal group (N), high-fat diet (HFD)-fed control group (Con), HFD+SYJST 100 mg/kg group (SY100), HFD+SYJST 200 mg/kg group (SY200), and HFD+olistat 60 mg/kg as a positive drug control group (Orli). Markers of obesity, such as body weight, liver weight, food intake, serum total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C), liver tissue TC, TG and fecal TC, TG were measured. Results In vitro, cytotoxicity was not significant compared with the control group. 3T3-L1 cell's differentiation was significantly decreased in Oil Red-O staining. In vivo, compared with controls, mice treated with SYJST demonstrate lower body and liver weight, and reduced food intake. In addition, SYJST increased TC, TG in the serum but not significance. And SYJST showed decreasing tendency TC, TG in the liver tissue. Furthermore, SYJST increased TC, TG in the facal but not significance. Conclusions Based on the results above, Seungyangjeseup-tang may reduce adipocyte differentiation, body fat, food intake, liver weight in obesity. This suggests that Seungyangjeseup-tang may be clinically useful in obesity treatment.